These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 14608378

  • 1. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
    Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA.
    Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
    [Abstract] [Full Text] [Related]

  • 2. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
    Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW.
    Ann Neurol; 2007 Jan; 61(1):61-72. PubMed ID: 17262851
    [Abstract] [Full Text] [Related]

  • 3. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM, Kohl B, Buhren BA, Hasenpusch-Theil K, Kruse F, Küry P, Martini R, Müller HW.
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.
    Mersiyanova IV, Ismailov SM, Polyakov AV, Dadali EL, Fedotov VP, Nelis E, Löfgren A, Timmerman V, van Broeckhoven C, Evgrafov OV.
    Hum Mutat; 2000 Mar; 15(4):340-7. PubMed ID: 10737979
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.
    Numakura C, Lin C, Ikegami T, Guldberg P, Hayasaka K.
    Hum Mutat; 2002 Nov; 20(5):392-8. PubMed ID: 12402337
    [Abstract] [Full Text] [Related]

  • 10. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.
    Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontés M.
    Nat Med; 2004 Apr; 10(4):396-401. PubMed ID: 15034573
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the myelin protein zero gene associated with Charcot-Marie-Tooth disease type 1B.
    Latour P, Blanquet F, Nelis E, Bonnebouche C, Chapon F, Diraison P, Ollagnon E, Dautigny A, Pham-Dinh D, Chazot G.
    Hum Mutat; 1995 Apr; 6(1):50-4. PubMed ID: 7550231
    [Abstract] [Full Text] [Related]

  • 12. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, Mancardi GL, Bartke I, Müller HW.
    J Neurosci Res; 1994 Apr 01; 37(5):654-9. PubMed ID: 8028042
    [Abstract] [Full Text] [Related]

  • 13. Mutation testing in Charcot-Marie-Tooth neuropathy.
    Nicholson GA.
    Ann N Y Acad Sci; 1999 Sep 14; 883():383-8. PubMed ID: 10586262
    [Abstract] [Full Text] [Related]

  • 14. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
    Naef R, Suter U.
    Neurobiol Dis; 1999 Feb 14; 6(1):1-14. PubMed ID: 10078969
    [Abstract] [Full Text] [Related]

  • 15. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
    Meyer zu Horste G, Miesbach TA, Muller JI, Fledrich R, Stassart RM, Kieseier BC, Coleman MP, Sereda MW.
    Neurobiol Dis; 2011 Apr 14; 42(1):1-8. PubMed ID: 21168501
    [Abstract] [Full Text] [Related]

  • 16. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.
    Kobsar I, Hasenpusch-Theil K, Wessig C, Müller HW, Martini R.
    J Neurosci Res; 2005 Sep 15; 81(6):857-64. PubMed ID: 16041800
    [Abstract] [Full Text] [Related]

  • 17. Mutations in the peripheral myelin protein zero and connexin32 genes detected by non-isotopic RNase cleavage assay and their phenotypes in Japanese patients with Charcot-Marie-Tooth disease.
    Yoshihara T, Yamamoto M, Doyu M, Mis KI, Hattori N, Hasegawa Y, Mokuno K, Mitsuma T, Sobue G.
    Hum Mutat; 2000 Aug 15; 16(2):177-8. PubMed ID: 10923043
    [Abstract] [Full Text] [Related]

  • 18. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.
    Choi BO, Lee MS, Shin SH, Hwang JH, Choi KG, Kim WK, Sunwoo IN, Kim NK, Chung KW.
    Hum Mutat; 2004 Aug 15; 24(2):185-6. PubMed ID: 15241803
    [Abstract] [Full Text] [Related]

  • 19. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study.
    Rautenstrauss B, Zechner U, Hameister H, Grehl H, Liehr T.
    J Peripher Nerv Syst; 1998 Aug 15; 3(2):117-24. PubMed ID: 10959245
    [Abstract] [Full Text] [Related]

  • 20. Animal models of inherited neuropathies.
    Meyer Zu Hörste G, Nave KA.
    Curr Opin Neurol; 2006 Oct 15; 19(5):464-73. PubMed ID: 16969156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.